Geode Capital Management, LLC Viridian Therapeutics, Inc.\De Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,720,525 shares of VRDN stock, worth $25.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,720,525

Previous 1,658,980 3.71%

Holding current value

$25.2 Million

Previous $31.8 Million 27.07%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$13.48 - $20.91 $829,626 - $1.29 Million	61,545 Added 3.71%	1,720,525 $23.2 Million
Q4 2024 Feb 12, 2025	BUY	$17.85 - $25.71 $2.96 Million - $4.26 Million	165,669 Added 11.09%	1,658,980 $31.8 Million
Q3 2024 Nov 12, 2024	BUY	$12.16 - $23.33 $996,524 - $1.91 Million	81,951 Added 5.81%	1,493,311 $34 Million
Q2 2024 Aug 09, 2024	BUY	$11.6 - $17.26 $2.87 Million - $4.26 Million	247,088 Added 21.22%	1,411,360 $18.4 Million
Q1 2024 May 13, 2024	BUY	$17.09 - $23.82 $2.9 Million - $4.04 Million	169,804 Added 17.07%	1,164,272 $20.4 Million
Q4 2023 Feb 13, 2024	BUY	$11.12 - $22.5 $1.51 Million - $3.05 Million	135,373 Added 15.76%	994,468 $21.7 Million
Q3 2023 Nov 13, 2023	SELL	$15.16 - $24.7 $26,711 - $43,521	-1,762 Reduced 0.2%	859,095 $13.2 Million
Q2 2023 Aug 11, 2023	BUY	$22.57 - $29.67 $1.91 Million - $2.51 Million	84,745 Added 10.92%	860,857 $20.5 Million
Q1 2023 May 15, 2023	BUY	$25.04 - $37.6 $1.63 Million - $2.45 Million	65,127 Added 9.16%	776,112 $19.7 Million
Q4 2022 Feb 13, 2023	BUY	$18.78 - $29.74 $2.09 Million - $3.31 Million	111,219 Added 18.54%	710,985 $20.8 Million
Q3 2022 Nov 14, 2022	BUY	$10.7 - $25.5 $1.61 Million - $3.83 Million	150,106 Added 33.38%	599,766 $12.3 Million
Q2 2022 Aug 12, 2022	BUY	$9.55 - $19.0 $2.39 Million - $4.76 Million	250,422 Added 125.69%	449,660 $5.2 Million
Q1 2022 May 13, 2022	SELL	$16.79 - $20.88 $40,967 - $50,947	-2,440 Reduced 1.21%	199,238 $3.68 Million
Q4 2021 Feb 11, 2022	BUY	$15.65 - $21.5 $2.2 Million - $3.02 Million	140,428 Added 229.27%	201,678 $3.99 Million
Q3 2021 Nov 12, 2021	BUY	$10.69 - $18.2 $245,517 - $417,999	22,967 Added 59.99%	61,250 $1.01 Million
Q2 2021 Aug 13, 2021	BUY	$14.34 - $18.67 $220,678 - $287,312	15,389 Added 67.22%	38,283 $700,000
Q1 2021 May 12, 2021	BUY	$15.5 - $24.93 $354,857 - $570,747	22,894 New	22,894 $382,000

Others Institutions Holding VRDN

# of Institutions

189

Shares Held

79.6M

Call Options Held

92.2K

Put Options Held

55.2K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $584M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Viridian Therapeutics, Inc.\De Transaction History